Kong S X, Wertheimer A I
Merck & Co., Whitehouse Station, NJ 08889, USA.
Am J Manag Care. 1998 Jan;4(1):28-34.
Medical and pharmaceutical outcomes research has been of increasing interest in the past 10 to 15 years among healthcare providers, payers, and regulatory agencies. Outcomes research has become a multidisciplinary field involving clinicians, health services researchers, epidemiologists, psychometricians, statisticians, psychologists, sociologists, economists, and ethicists. Collaboration among researchers in different organizations that offer different types of services and various research expertise is the essential element for any successful outcomes project. In this article we discuss collaboration on outcomes research among academic researchers (mainly those who work in colleges of pharmacy), managed care organizations, and research-based pharmaceutical manufacturers, with a focus on the opportunities and challenges facing each party. The pharmaceutical industry needs information to make product and promotion decisions; the managed care industry has data to offer but needs analysis of these data; and pharmacy schools, among other academic institutions, have skilled researchers and data-processing capacity but require projects for revenue, research training, experience, and publications. Challenges do exist with such endeavors, but collaboration could be beneficial in satisfying the needs of the individual parties.
在过去10到15年里,医疗和制药成果研究越来越受到医疗服务提供者、支付方及监管机构的关注。成果研究已成为一个多学科领域,涉及临床医生、卫生服务研究人员、流行病学家、心理测量学家、统计学家、心理学家、社会学家、经济学家和伦理学家。不同组织中提供不同类型服务且具备各种研究专长的研究人员之间的合作,是任何成功的成果项目的关键要素。在本文中,我们将讨论学术研究人员(主要是药学院的研究人员)、管理式医疗组织和以研究为基础的制药制造商在成果研究方面的合作,重点关注各方面临的机遇和挑战。制药行业需要信息来做出产品和推广决策;管理式医疗行业有数据可供提供,但需要对这些数据进行分析;药学院以及其他学术机构拥有技术娴熟的研究人员和数据处理能力,但需要项目来获取收入、进行研究培训、积累经验和发表论文。此类合作确实存在挑战,但合作可能有利于满足各方的需求。